Repayment of Borrowings Through New Share Issuance and Securing Investment Capacity
First written in FY2021-Q2. 14 of 16 entries say "Advanced", first in FY2021-Q3. Latest entry: FY2026.
5 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「This was mainly because cash outflows of ¥4,772 million from the repayment of long-term borrowings, ¥1,253 million from the repayment of lease liabilities and ¥1,045 million in dividend payments were recorded, while cash inflows of ¥5,744 million from long-term borrowings were recorded.」
Obtained ¥5,744 million in long-term borrowings, while repaying ¥4,772 million in long-term borrowings. The balance of borrowings at the fiscal year-end increased from ¥38,279 million to ¥41,499 million. - 2026-05-08AdvancedRevision to earnings forecasts
「Cash used in financing activities was ¥1,265 million, compared with cash provided of ¥6,484 million in the previous consolidated fiscal year. This was mainly due to proceeds of ¥5,744 million from long-term borrowings, offset by repayments of long-term borrowings of ¥4,772 million, repayments of lease liabilities of ¥1,253 million, and dividend payments of ¥1,045 million.」
The company raised ¥5,744 million through long-term borrowings and repaid ¥4,772 million of long-term borrowings, with financing and repayment activity continuing in connection with acquisitions and other matters. - FY2026-H1AdvancedAnnual report
「This was mainly because cash outflows of ¥2,304 million from the repayment of long-term borrowings and ¥1,045 million in dividend payments were recorded, while cash inflows of ¥5,744 million from long-term borrowings were recorded.」
During the interim period, obtained ¥5,744 million in long-term borrowings, while repaying ¥2,304 million in long-term borrowings. The balance of borrowings increased from ¥38,279 million at the end of the previous fiscal year to ¥43,760 million. - FY2025AdvancedAnnual report
「Recorded cash inflows of ¥32,195 million from long-term borrowings, while recording cash outflows of ¥16,003 million from the repayment of short-term borrowings and ¥7,903 million from the repayment of long-term borrowings.」
Obtained ¥32,195 million in long-term borrowings to meet funding needs for acquisitions and other purposes, while repaying short- and long-term borrowings. The balance of borrowings at the fiscal year-end amounted to ¥38,279 million. - FY2025-H1AdvancedAnnual report
「Funds provided by financing activities amounted to ¥6,729 million. This was mainly because cash outflows of ¥2,916 million from the repayment of long-term borrowings, ¥1,803 million from the repayment of short-term borrowings and ¥914 million in dividend payments were recorded, while cash inflows of ¥12,707 million from long-term borrowings were recorded.」
During the six-month consolidated accounting period, obtained ¥12,707 million in long-term borrowings, while repaying ¥2,916 million in long-term borrowings and ¥1,803 million in short-term borrowings. The balance of borrowings at the period-end increased from ¥28,927 million to ¥37,978 million. - FY2024AdvancedAnnual report
「Our group’s basic policy is to fund working capital and capital expenditures through retained earnings. However, if funding needs arise from the acquisition of investment securities for the purpose of acquiring companies, we may obtain external financing as necessary. At the end of the consolidated fiscal year, borrowings under current liabilities amounted to ¥22,352 million and borrowings under non-current liabilities amounted to ¥6,574 million.」
Explicitly stated a financing policy of obtaining external funding for acquisitions, with total borrowings at the fiscal year-end amounting to ¥28,927 million. - FY2024-Q3AdvancedAnnual report
「This was mainly because cash inflows of ¥1,701 million from short-term borrowings, ¥2,528 million from long-term borrowings and ¥2,197 million from the exercise of share acquisition rights were recorded, while dividend payments of ¥754 million and cash outflows of ¥2,327 million from the repayment of long-term borrowings were recorded.」
As part of fund management following the new share issue, continued raising funds through borrowings, repayments and the exercise of share acquisition rights. - FY2023-Q3AdvancedAnnual report
「In July 2022, we drew down ¥19,330 million in borrowings to fund multiple share acquisitions, including amounts already paid, and repaid the full amount ahead of schedule in November of the same year.」
Fully repaid in November the ¥19,330 million borrowing drawn down to fund multiple share acquisitions. Fund management through borrowings and repayments following the new share issue progressed in concrete terms. - FY2023-Q2AdvancedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, we issued new shares through an international offering and a third-party allotment to Omron Corporation, recording ¥29,212 million in proceeds from the share issues. The purpose was to secure financial capacity for ongoing and timely development of new businesses and M&A to capture abundant business opportunities in the health big data field.」
Raised ¥29,212 million through a new share issue comprising an international offering and a third-party allotment to Omron, with plans to use the proceeds to repay M&A borrowings, replenish reduced cash and deposits, and fund capital investment. - FY2023-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 27 July 2022, we resolved to obtain borrowings.」
Resolved to obtain ¥19,330 million in floating-rate borrowings from Mizuho Bank to fund multiple share acquisitions, and drew down the funds on 28 July 2022. The measure of repaying borrowings and securing investment capacity following the new share issue progressed to the specific financing of acquisition funds. - FY2022AdvancedAnnual report
「This was mainly because cash outflows of ¥2,622 million from the repayment of short-term borrowings and ¥784 million from the repayment of long-term borrowings were recorded, while cash inflows of ¥1,470 million from long-term borrowings were recorded.」
As part of fund management following the new share issue, short- and long-term borrowings were repaid and new long-term borrowings were obtained, reducing the balance of borrowings from ¥13,422 million to ¥11,705 million. - FY2022-Q3AdvancedAnnual report
「This was mainly because cash outflows of ¥2,622 million from the repayment of short-term borrowings and ¥590 million from the repayment of long-term borrowings were recorded, while cash inflows of ¥1,470 million from long-term borrowings were recorded.」
Disclosed that, as part of fund management following the new share issue, short-term borrowings of ¥2,622 million and long-term borrowings of ¥590 million were repaid, while ¥1,470 million in long-term borrowings was obtained. - FY2022-Q2RestatedAnnual report
「This was mainly because cash outflows of ¥2,622 million from the repayment of short-term borrowings were recorded, while cash inflows of ¥1,470 million from long-term borrowings were recorded.」
Continued managing funds by combining repayment of short-term borrowings with new long-term borrowings. No new change in purpose or completion of the measures described through the previous quarter was indicated. - FY2022-Q1AdvancedAnnual report
「This was mainly because borrowings under current liabilities decreased by ¥2,534 million as a result of repaying and obtaining new borrowings, while borrowings under non-current liabilities increased by ¥1,225 million, as well as because a peer company joined our group in the dispensing pharmacy support segment.」
As a financial measure following the new share issue, borrowings were repaid, reducing borrowings under current liabilities by ¥2,534 million. Borrowings under non-current liabilities increased by ¥1,225 million. - FY2021-Q3AdvancedAnnual report
「As a result of issuing new shares through an international offering with a payment date of 24 November 2020 to secure funds for repaying existing borrowings, cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year amounted to ¥18,582 million, while borrowings under current liabilities amounted to ¥3,278 million and borrowings under non-current liabilities amounted to ¥10,301 million.」
The new share issue through an international offering planned as of the second quarter was completed on 24 November 2020, and ¥10,714 million in proceeds from the share issue was recorded. Although the purpose was to secure funds for repaying existing borrowings, this filing does not state that repayment had been completed. - FY2021-Q2First statedAnnual report
「Our aim is to improve our financial position by securing funds to repay existing borrowings, establish a structure enabling us to make timely investments by using the resulting borrowing capacity from financial institutions, capture major business investment opportunities without missing them, accelerate growth, and enhance the enterprise value of our group and shareholder value.」
For the issuance of 2 million common shares through an international offering scheduled for payment on 24 November 2020, raised total proceeds of ¥10,714.4 million and recorded for the first time a measure aimed at repaying existing borrowings and making timely business investments using borrowing capacity.